January 15, 2023
1 min watch
Save
VIDEO: Gene therapy options being explored for AMD, diabetic retinopathy
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Allen C. Ho, MD, discusses gene therapy for wet and dry age-related macular degeneration and diabetic retinopathy.
“We have an approved gene therapy for an inherited retinal degeneration — Leber’s congenital amaurosis,” he said. “We are in pivotal trials for wet AMD and in phase 1 and 2 trials for atrophic AMD and diabetic retinopathy. It’s great science. We’re looking at different ways of delivering the gene therapy.”
Published by:
Sources/Disclosures
Collapse
Source:
Ho AC. Gene therapy for AMD and DR. Presented at: Hawaiian Eye 2023; Jan. 14-20, 2023; Koloa, Hawaii.
Disclosures:
Ho reports consulting for AbbVie, Adverum, Gyroscope, Novartis and Regenxbio.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.